ADVERTISEMENTREMOVE AD

Video | Omicron COVID-19 Variant Symptoms & Treatment: What to Know

Published
Coronavirus
2 min read
Aa
Aa
Small
Aa
Medium
Aa
Large

With the COVID-19 cases once again soaring in the country, so are concerns surrounding the new COVID-19 variant of Concern, Omicron.

How does Omicron compare to the Delta Variant?

Is it really milder than Delta?

Are there any new symptoms associated with Omicron?

What treatment options and drugs work against the variant and which don't?

Dr Pinank Pandya, Senior intensivist at Jaslok Hospital, joins FIT to answer these questions and help shed some light on what the situation is looking like in the hospitals.

How is Omicron Different from Delta?

"The first thing is that it is more transmissible than the Delta variant," says Dr Pinank Pandya, Senior intensivist at Jaslok Hospital.

"It is approximately ten times more transmissible than the delta variant."
Dr Pinank Pandya, Senior intensivist at Jaslok Hospital
ADVERTISEMENTREMOVE AD

Two other observations that Dr Pandya makes are that,

  • Patients are mostly experiencing mild symptoms.

"In this week or so that we have seen the patients, the patients are not appearing to have major symptoms. They are getting better with symptomatic therapies alone," he says.

  • Even people who are fully vaccinated are getting infected.

Dr Pandya also goes on to say that another point of difference is in the symptoms. While there are some common symptoms like fever and cough, he says, "there is no breathlessness that we're seeing this time."

Some of the symptoms that weren't associated with COVID-19, that they are seeing now are,

  • Headache

  • Nasal heaviness or blockage

  • Body ache

  • Excessive fatigue

Treatment Options: The Dos and Don'ts

Dr Pandya goes on to talk about some drugs which were being used to treat COVID in the second and first waves, but are no longer being prescribed due to a lack of data to support their effectiveness in fighting the viral infection.

Some of the drugs he listed are,

Speaking of the Merck's COVID-19 pill, Molnupiravir, he says, "these are also approved only for patients with mild and moderate symptoms and they come with alot of side effects, so we have to take it with a pinch of salt."

"The treatment largely remains symptomatic. The main thing will be isolation because it is rapidly transmissible," he adds.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

0

Read Latest News and Breaking News at The Quint, browse for more from fit and coronavirus

Topics:  COVID-19   Omicron   omicron COVID variant 

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
×
×